Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Gough

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Nature Communications|September 27, 2018
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95LLucia Taraborrelli, Nieves Peltzer, Antonella Montinaro, et al.
Science (New York, N.Y.)|October 27, 2018
Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell deathPontus Orning, Dan Weng, Kristian Starheim, et al.
The Journal of Experimental Medicine|September 1, 2017
RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defenseLance W Peterson, Naomi H Philip, Alexandra DeLaney, et al.
Plos One|April 3, 2014
Pathogen sensing pathways in human embryonic stem cell derived-endothelial cells: role of NOD1 receptorsDaniel M Reed, Gabor Foldes, Timothy Gatheral, et al.
Nature|September 5, 2014
RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosisNozomi Takahashi, Lars Vereecke, Mathieu J M Bertrand, et al.
Pharmacology Research & Perspectives|December 12, 2017
Identification of an antibody-based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissuesJoshua N Finger, Jean-Marie Brusq, Nino Campobasso, et al.
Plos One|May 13, 2015
MALT1 Protease Activity Is Required for Innate and Adaptive Immune ResponsesJong W Yu, Sandy Hoffman, Allison M Beal, et al.
Bioorganic & Medicinal Chemistry|October 13, 2015
Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivityAdam K Charnley, Máire A Convery, Ami Lakdawala Shah, et al.
Plos One|August 13, 2013
Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathwayDavid J Rickard, Clark A Sehon, Viera Kasparcova, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell deathDan Weng, Robyn Marty-Roix, Sandhya Ganesan, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Nature Communications|September 27, 2018
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95LLucia Taraborrelli, Nieves Peltzer, Antonella Montinaro, et al.
Science (New York, N.Y.)|October 27, 2018
Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell deathPontus Orning, Dan Weng, Kristian Starheim, et al.
The Journal of Experimental Medicine|September 1, 2017
RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defenseLance W Peterson, Naomi H Philip, Alexandra DeLaney, et al.
Plos One|April 3, 2014
Pathogen sensing pathways in human embryonic stem cell derived-endothelial cells: role of NOD1 receptorsDaniel M Reed, Gabor Foldes, Timothy Gatheral, et al.
Nature|September 5, 2014
RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosisNozomi Takahashi, Lars Vereecke, Mathieu J M Bertrand, et al.
Pharmacology Research & Perspectives|December 12, 2017
Identification of an antibody-based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissuesJoshua N Finger, Jean-Marie Brusq, Nino Campobasso, et al.
Plos One|May 13, 2015
MALT1 Protease Activity Is Required for Innate and Adaptive Immune ResponsesJong W Yu, Sandy Hoffman, Allison M Beal, et al.
Bioorganic & Medicinal Chemistry|October 13, 2015
Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivityAdam K Charnley, Máire A Convery, Ami Lakdawala Shah, et al.
Plos One|August 13, 2013
Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathwayDavid J Rickard, Clark A Sehon, Viera Kasparcova, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell deathDan Weng, Robyn Marty-Roix, Sandhya Ganesan, et al.
Pageof 8